143 related articles for article (PubMed ID: 38065194)
1. Postoperative radiotherapy omission in selected patients with early breast cancer following preoperative breast MRI (PROSPECT): primary results of a prospective two-arm study.
Mann GB; Skandarajah AR; Zdenkowski N; Hughes J; Park A; Petrie D; Saxby K; Grimmond SM; Murugasu A; Spillane AJ; Chua BH; Badger H; Braggett H; Gebski V; Mou A; Collins JP; Rose AK
Lancet; 2024 Jan; 403(10423):261-270. PubMed ID: 38065194
[TBL] [Abstract][Full Text] [Related]
2. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial.
Kunkler IH; Williams LJ; Jack WJ; Cameron DA; Dixon JM;
Lancet Oncol; 2015 Mar; 16(3):266-73. PubMed ID: 25637340
[TBL] [Abstract][Full Text] [Related]
3. Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.
King MT; Link EK; Whelan TJ; Olivotto IA; Kunkler I; Westenberg AH; Gruber G; Schofield P; Chua BH;
Lancet Oncol; 2020 May; 21(5):685-698. PubMed ID: 32203696
[TBL] [Abstract][Full Text] [Related]
4. Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial.
Coles CE; Griffin CL; Kirby AM; Titley J; Agrawal RK; Alhasso A; Bhattacharya IS; Brunt AM; Ciurlionis L; Chan C; Donovan EM; Emson MA; Harnett AN; Haviland JS; Hopwood P; Jefford ML; Kaggwa R; Sawyer EJ; Syndikus I; Tsang YM; Wheatley DA; Wilcox M; Yarnold JR; Bliss JM;
Lancet; 2017 Sep; 390(10099):1048-1060. PubMed ID: 28779963
[TBL] [Abstract][Full Text] [Related]
5. Multicentre randomised controlled trial examining the cost-effectiveness of contrast-enhanced high field magnetic resonance imaging in women with primary breast cancer scheduled for wide local excision (COMICE).
Turnbull LW; Brown SR; Olivier C; Harvey I; Brown J; Drew P; Hanby A; Manca A; Napp V; Sculpher M; Walker LG; Walker S;
Health Technol Assess; 2010 Jan; 14(1):1-182. PubMed ID: 20025837
[TBL] [Abstract][Full Text] [Related]
6. Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEA.
Jagsi R; Griffith KA; Harris EE; Wright JL; Recht A; Taghian AG; Lee L; Moran MS; Small W; Johnstone C; Rahimi A; Freedman G; Muzaffar M; Haffty B; Horst K; Powell SN; Sharp J; Sabel M; Schott A; El-Tamer M
J Clin Oncol; 2024 Feb; 42(4):390-398. PubMed ID: 38060195
[TBL] [Abstract][Full Text] [Related]
7. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.
van Maaren MC; de Munck L; de Bock GH; Jobsen JJ; van Dalen T; Linn SC; Poortmans P; Strobbe LJA; Siesling S
Lancet Oncol; 2016 Aug; 17(8):1158-1170. PubMed ID: 27344114
[TBL] [Abstract][Full Text] [Related]
8. A randomised controlled trial of postoperative radiotherapy following breast-conserving surgery in a minimum-risk older population. The PRIME trial.
Prescott RJ; Kunkler IH; Williams LJ; King CC; Jack W; van der Pol M; Goh TT; Lindley R; Cairns J
Health Technol Assess; 2007 Aug; 11(31):1-149, iii-iv. PubMed ID: 17669280
[TBL] [Abstract][Full Text] [Related]
9. Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. Uppsala-Orebro Breast Cancer Study Group.
Liljegren G; Holmberg L; Adami HO; Westman G; Graffman S; Bergh J
J Natl Cancer Inst; 1994 May; 86(9):717-22. PubMed ID: 8158702
[TBL] [Abstract][Full Text] [Related]
10. Receipt of mastectomy and adjuvant radiotherapy following breast conserving surgery (BCS) in New Zealand women with BCS-eligible breast cancer, 2010-2015: an observational study focusing on ethnic differences.
Bartholomew K; Ghafel M; Tin Tin S; Aye PS; Elwood JM; Hardie C; Scott N; Kidd J; Ramsaroop R; Campbell I
BMC Cancer; 2023 Aug; 23(1):766. PubMed ID: 37592208
[TBL] [Abstract][Full Text] [Related]
11. One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT.
Brunt AM; Haviland JS; Wheatley DA; Sydenham MA; Bloomfield DJ; Chan C; Cleator S; Coles CE; Donovan E; Fleming H; Glynn D; Goodman A; Griffin S; Hopwood P; Kirby AM; Kirwan CC; Nabi Z; Patel J; Sawyer E; Somaiah N; Syndikus I; Venables K; Yarnold JR; Bliss JM;
Health Technol Assess; 2023 Nov; 27(25):1-176. PubMed ID: 37991196
[TBL] [Abstract][Full Text] [Related]
12. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
Fodor J; Mózsa E; Zaka Z; Polgár C; Major T
Magy Onkol; 2005; 49(3):203, 205-8. PubMed ID: 16249814
[TBL] [Abstract][Full Text] [Related]
13. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial.
Veronesi U; Orecchia R; Maisonneuve P; Viale G; Rotmensz N; Sangalli C; Luini A; Veronesi P; Galimberti V; Zurrida S; Leonardi MC; Lazzari R; Cattani F; Gentilini O; Intra M; Caldarella P; Ballardini B
Lancet Oncol; 2013 Dec; 14(13):1269-77. PubMed ID: 24225155
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant radiotherapy after breast conserving surgery - a comparative effectiveness research study.
Corradini S; Niyazi M; Niemoeller OM; Li M; Roeder F; Eckel R; Schubert-Fritschle G; Scheithauer HR; Harbeck N; Engel J; Belka C
Radiother Oncol; 2015 Jan; 114(1):28-34. PubMed ID: 25236715
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of Breast-Conserving Surgery and 3-Dimensional Conformal Partial Breast Reirradiation for Recurrence of Breast Cancer in the Ipsilateral Breast: The NRG Oncology/RTOG 1014 Phase 2 Clinical Trial.
Arthur DW; Winter KA; Kuerer HM; Haffty B; Cuttino L; Todor DA; Anne PR; Anderson P; Woodward WA; McCormick B; Cheston S; Sahijdak WM; Canaday D; Brown DR; Currey A; Fisher CM; Jagsi R; Moughan J; White JR
JAMA Oncol; 2020 Jan; 6(1):75-82. PubMed ID: 31750868
[TBL] [Abstract][Full Text] [Related]
16. Omitting radiotherapy in women ≥ 65 years with low-risk early breast cancer after breast-conserving surgery and adjuvant endocrine therapy is safe.
Wickberg Å; Liljegren G; Killander F; Lindman H; Bjöhle J; Carlberg M; Blomqvist C; Ahlgren J; Villman K
Eur J Surg Oncol; 2018 Jul; 44(7):951-956. PubMed ID: 29709338
[TBL] [Abstract][Full Text] [Related]
17. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial.
Vaidya JS; Joseph DJ; Tobias JS; Bulsara M; Wenz F; Saunders C; Alvarado M; Flyger HL; Massarut S; Eiermann W; Keshtgar M; Dewar J; Kraus-Tiefenbacher U; Sütterlin M; Esserman L; Holtveg HM; Roncadin M; Pigorsch S; Metaxas M; Falzon M; Matthews A; Corica T; Williams NR; Baum M
Lancet; 2010 Jul; 376(9735):91-102. PubMed ID: 20570343
[TBL] [Abstract][Full Text] [Related]
18. Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial.
Vicini FA; Cecchini RS; White JR; Arthur DW; Julian TB; Rabinovitch RA; Kuske RR; Ganz PA; Parda DS; Scheier MF; Winter KA; Paik S; Kuerer HM; Vallow LA; Pierce LJ; Mamounas EP; McCormick B; Costantino JP; Bear HD; Germain I; Gustafson G; Grossheim L; Petersen IA; Hudes RS; Curran WJ; Bryant JL; Wolmark N
Lancet; 2019 Dec; 394(10215):2155-2164. PubMed ID: 31813636
[TBL] [Abstract][Full Text] [Related]
19. Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma In Situ of the Breast.
Rivera R; Banks A; Casillas-Lopez A; Rashtian A; Lewinsky B; Sheth P; Hovannesian-Larsen L; Brousseau D; Iyengar G; Holmes DR
Breast J; 2016; 22(1):63-74. PubMed ID: 26534876
[TBL] [Abstract][Full Text] [Related]
20. No breast cancer subgroup can be spared postoperative radiotherapy after breast-conserving surgery. Fifteen-year results from the Swedish Breast Cancer Group randomised trial, SweBCG 91 RT.
Killander F; Karlsson P; Anderson H; Mattsson J; Holmberg E; Lundstedt D; Holmberg L; Malmström P
Eur J Cancer; 2016 Nov; 67():57-65. PubMed ID: 27614164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
